Clinical trials
Sleep Apnea, Obstructive trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 7 |
| Recruiting | 5 |
| Terminated | 5 |
| Active, not recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Zurich | 15 |
| Centre Hospitalier Universitaire Vaudois | 5 |
| Insel Gruppe AG, University Hospital Bern | 3 |
| Malcolm Kohler | 3 |
| Raphael Heinzer | 3 |
| Bayer | 2 |
| Inspire Medical Systems, Inc. | 2 |
| Cantonal Hosptal, Baselland | 1 |
| Dr. Med Anas Taha | 1 |
| Haute Ecole de Santé Vaud | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Apnea, Obstructive | 52 |
| Sleep Apnea Syndromes | 12 |
| Kidney Failure, Chronic | 4 |
| Apnea | 3 |
| Water Intoxication | 3 |
| Aortic Aneurysm | 2 |
| Ehlers-Danlos Syndrome | 2 |
| Hypoxia | 2 |
| Sleep Apnea, Central | 2 |
| Sleepiness | 2 |
Trials
Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.